Treating COVID-19 using Micro RNA
Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists. By time, COVID-19 has developed and adapted to the surrounding spread prohibitions. That resulted in an incredible increase in the rate of death, in particular for old people who are suffering from other diseases and have frailty in their immunity that permit viruses attacks. Various dense research is under working, as a way to uncover a cure or a vaccine on the long term. Hence, this paper focuses the lights on treating COVID-19 using a brand-new method of non-coding RNA (ncRNA)..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Journal de la Faculté de Médecine d'Oran - 7(2023), 1 |
| Sprache: |
Englisch ; Französisch |
|---|
| Beteiligte Personen: |
Eskandar Kirolos [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
Coronavirus disease 2019 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ09205255X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ09205255X | ||
| 003 | DE-627 | ||
| 005 | 20240414130513.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ09205255X | ||
| 035 | |a (DE-599)DOAJ523b6070b0f242b2bf56a21d7661f44c | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a fre | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Eskandar Kirolos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treating COVID-19 using Micro RNA |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists. By time, COVID-19 has developed and adapted to the surrounding spread prohibitions. That resulted in an incredible increase in the rate of death, in particular for old people who are suffering from other diseases and have frailty in their immunity that permit viruses attacks. Various dense research is under working, as a way to uncover a cure or a vaccine on the long term. Hence, this paper focuses the lights on treating COVID-19 using a brand-new method of non-coding RNA (ncRNA). | ||
| 650 | 4 | |a Coronavirus disease 2019 | |
| 650 | 4 | |a Non-coding RNA | |
| 650 | 4 | |a Micro-RNA | |
| 650 | 4 | |a Treatment for Corona virus | |
| 653 | 0 | |a Medicine (General) | |
| 773 | 0 | 8 | |i In |t Journal de la Faculté de Médecine d'Oran |d University of Oran 1, 2022 |g 7(2023), 1 |w (DE-627)DOAJ078601061 |x 26026511 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:1 |
| 856 | 4 | 0 | |u https://doaj.org/article/523b6070b0f242b2bf56a21d7661f44c |z kostenfrei |
| 856 | 4 | 0 | |u https://www.ajol.info/index.php/jfmo/article/view/250063 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2571-9874 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2602-6511 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 1 | ||